Inoue A, Robinson FS, Minelli R, Tomihara H, et al. Sequential administration of XPO1 and ATR inhibitors enhances therapeutic response in TP53-mutated colorectal cancer. Gastroenterology 2021 Mar 18. pii: S0016-5085(21)00530.
PMID: 33745946